Company
Company
Our mission is to be the global scientific, clinical and commercial leader in the production of treatment for patients in crisis with medical conditions that cause ischemia, such as hemorrhagic shock and sickle cell disease.
- Based in San Diego, CA
- Founded in 1998
- Built on more than 30 years of research